Find Locations
For hours, walk-ins and appointments.Synonyms
- 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase
- Anti-HMGCOAHMG-CoA Reductase
- HMGCOA
Expected Turnaround Time
Three times per week
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Gel-barrier tube or red-top tube
Collection
If a red-top tube is used, transfer separated serum to a plastic transport tube.
Storage Instructions
Refrigerate or freeze.
Stability Requirements
| Temperature | Period |
|---|---|
| Room temperature | 48 hours |
| Refrigerated | 14 days |
| Frozen | 14 days |
| Freeze/thaw cycles | Stable x3 |
Causes for Rejection
Gross hemolysis; lipemia and icterus
Test Details
Use
This test detects antibodies against HMGCR for diagnosis of necrotizing myopathy.
Limitations
1. Not all idiopathic inflammatory myopathy patients are positive for HMGCR antibodies.
2. Results of this assay should be used in conjunction with clinical findings and other serological tests.
3. Failure to adequately resuspend the HMGCR coated beads may yield lower values than if the beads are properly re-suspended.
4. The performance characteristics of this assay have not been established for matrices other than serum.
Methodology
Chemiluminescence Immunoassay
References
Bottai M, Tjarnlund A, Santoni G, et al. EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open. 2017 Nov 14;3(2):e000507. 29177080
Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010 Sep;62(9):2757-2766. 20496415
Musset L, Allenbach Y, Benveniste O, et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmun Rev. 2016 Oct;15(10):983-993. 27491568
© 2025 Laboratory Corporation of America® Holdings. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf